NuSkin Enterprises NUS Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $198.65M-2.5% | $238.63M+27.7% | $251.79M+10.6% | $264.16M+17.8% | $203.77M-4.1% | ||
| $1.75M-82.1% | $1.21M-89.1% | $1.21M-88.0% | $1.21M-86.0% | $9.78M+12.8% | ||
| $45.01M-20.4% | $39.54M-22.1% | $48.89M-28.9% | $59.7M-16.6% | $56.58M-15.6% | ||
| $178.6M-5.4% | $178.64M-6.1% | $178.53M-27.9% | $180.38M-26.1% | $188.78M-28.8% | ||
| $522.89M-0.4% | $547.7M+1.7% | $548.14M-16.1% | $571.55M-12.7% | $524.86M-18.9% | ||
| $381.61M+0.4% | $377.17M-0.6% | $375.28M-8.6% | $374.21M-9.2% | $380.07M-10.1% | ||
| $83.63M0.0% | $83.63M0.0% | $83.63M-16.3% | $83.63M-16.3% | $83.63M-63.8% | ||
| $39.29M-17.4% | $42.61M-42.6% | $44.2M-48.2% | $45.94M-48.1% | $47.55M-53.3% | ||
| $1.38B-1.1% | $1.41B-4.3% | $1.42B-10.0% | $1.44B-9.0% | $1.39B-20.1% | ||
| $28.82M-14.2% | $26.18M-24.9% | $28.52M-12.9% | $28.73M-20.9% | $33.59M+4.2% | ||
| $6.2M-17.3% | $7.2M-7.7% | $7.3M-36.5% | $7.4M-37.3% | $7.5M-37.0% | ||
| $20M0.0% | $20M-33.3% | $20M-66.7% | $35M+16.7% | $20M-33.3% | ||
| $257M-1.3% | $263.73M-11.1% | $254.44M-25.0% | $283.91M-8.0% | $260.3M-15.8% | ||
| $203.59M-6.9% | $204.19M-43.8% | $209.04M-44.0% | $213.9M-50.1% | $218.76M-51.7% | ||
| $582.71M-8.6% | $600.07M-26.6% | $624.61M-28.7% | $655.94M-27.1% | $637.44M-31.6% | ||
| 500M0.0% | 500M+549,351% | 500M0.0% | 500M0.0% | 500M0.0% | ||
| $1.86B+2.4% | $1.86B+8.7% | $1.85B+5.6% | $1.83B+5.1% | $1.82B-2.7% | ||
| $794.09M+5.3% | $805.24M+23.6% | $799.8M+13.1% | $787.75M+14.8% | $753.97M-6.9% | ||
| $1.38B-1.1% | $1.41B-4.3% | $1.42B-10.0% | $1.44B-9.0% | $1.39B-20.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does NuSkin Enterprises's balance sheet data come from?
- Every line is extracted from NuSkin Enterprises's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.